Silvia Bonanno Selected Research

Amifampridine

11/2022	Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial.
1/2018	Amifampridine phosphate in the treatment of muscle-specific kinase myasthenia gravis: a phase IIb, randomized, double-blind, placebo-controlled, double crossover study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvia Bonanno Research Topics

Disease

6	Myasthenia Gravis 01/2020 - 01/2011
5	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 11/2022 - 01/2020
5	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2020 - 01/2015
3	Disease Progression 06/2022 - 01/2020
3	Inflammation (Inflammations) 12/2020 - 04/2016
2	Paresthesia (Dysesthesia) 11/2022 - 01/2018
2	Multiple Sclerosis 02/2022 - 03/2011
1	Abducens Nerve Diseases (Sixth Nerve Palsy) 03/2022
1	Muscular Atrophy (Muscle Atrophy) 05/2021
1	Myotonia 01/2021
1	Channelopathies 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Paralysis (Palsy) 01/2021
1	Neuroinflammatory Diseases 12/2020
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2020
1	Glycogen Storage Disease Type II (Pompe's Disease) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Fatigue 01/2018
1	Epilepsy (Aura) 11/2017
1	Brain Neoplasms (Brain Tumor) 11/2017
1	Communicable Diseases (Infectious Diseases) 11/2016
1	Autoimmune Diseases (Autoimmune Disease) 04/2016
1	Epstein-Barr Virus Infections 04/2016

Drug/Important Bio-Agent (IBA)

5	MicroRNAs (MicroRNA)IBA 05/2021 - 01/2015
4	nusinersenIBA 06/2022 - 11/2020
3	Pharmaceutical PreparationsIBA 01/2019 - 01/2017
2	AmifampridineIBA 11/2022 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 11/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2020
2	Immunoglobulin G (IgG)IBA 02/2022 - 01/2019
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 04/2016
2	AutoantibodiesIBA 01/2020 - 01/2011
2	AntibodiesIBA 01/2020 - 01/2019
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019 - 11/2017
2	Riluzole FDA LinkGeneric 01/2019 - 11/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 02/2022
1	VaccinesIBA 02/2022
1	BNT162 VaccineIBA 02/2022
1	Ion Channels (Ion Channel)IBA 01/2021
1	ChemokinesIBA 12/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	FM19G11IBA 01/2019
1	human GAA protein (Myozyme)FDA Link 01/2019
1	Phosphotransferases (Kinase)IBA 01/2018
1	XenobioticsIBA 11/2017
1	EnzymesIBA 01/2017
1	Azathioprine (Imuran)FDA LinkGeneric 01/2017
1	Interleukin-4 (Interleukin 4)IBA 11/2016
1	Messenger RNA (mRNA)IBA 11/2016
1	Antiviral Agents (Antivirals)IBA 04/2016
1	Cholinergic ReceptorsIBA 04/2016
1	Dihydrotachysterol (AT 10)IBA 01/2016
1	AntigensIBA 01/2011

Therapy/Procedure

4	Therapeutics 06/2022 - 01/2011
1	Denervation 12/2020
1	Precision Medicine 10/2019
1	Enzyme Replacement Therapy 01/2019
1	Activities of Daily Living (ADL) 01/2018
1	Drug Therapy (Chemotherapy) 11/2017